Call us! (866) 936-3089
Welcome to PCI | HealthDev
Your source for medical real estate solutions
PCI | HealthDev offers physicians, practices, and healthcare providers a
wide range of medical real estate solutions. Whether you want to finance
and develop your medical facility or enhance your liquidity position by
monetizing your existing facility, our solutions are designed to help you
achieve your real estate goals
PCI | HealthDev offers:
• Distinctive medical real estate development solutions
• Monetization of existing real estate
• Robust asset management services
PCI | HealthDev: Medical Real Estate Solutions
PCI | HealthDev is a national healthcare real estate developer. Our
solutions - development of new buildings and monetization of existing
assets - enable physicians to own their medical real estate. We streamline
financing, construction, and ownership, so physicians can focus on what
they do best: delivering quality care.
PCI | HealthDev has financed and developed
medical offices and clinical facilities across the United States. View our
Making Your Medical Facility an Investment Opportunity
Our commitment to our clients includes:
• Developing best-in-class medical office buildings
• Delivering turnkey real estate solutions for healthcare professionals
• Providing value through expertise in:
- Site selection and land development
- Real estate financing
- Cost-effective design and construction
- Project management
- Real estate asset management
PCI | HealthDev Board of Directors
Co-Chairman and Board Member
Gregg brings a wealth of expertise to PCI | HealthDev and Caduceus Medical Holdings, Inc. with his experience in executive roles contributing to the management, operations, control and growth of financial services and healthcare-related companies. In particular, Gregg has an extensive background managing finance, accounting, and treasury organizations with responsibility for the associated financial planning and analyses, accounting and reporting, management and capital structure, information technology and control systems, as well as the identification and evaluation of strategic investment opportunities. Additionally, he has a significant background working with the SEC and in mergers and acquisitions.
Most recently, Gregg served as Senior VP/Chief Accounting Officer at First Data Corporation, a Fortune 250 Company, for five years. While at FDC, he served as an executive lead in the public spin out of The Western Union Company and the sale of FDC to KKR in one of the five biggest private equity LBO deals executed to that date. Prior to FDC, Gregg served as Senior VP/CFO of Gambro Healthcare (acquired by DaVita in 2004) where he spent more than 10 years, including time with affiliated companies. He began his career with 13 years at the public accounting firm Ernst & Young (and one of its predecessors, Arthur Young). Gregg currently serves on the boards of KMG Capital Partners, LLC, Caduceus Medical Holdings, Inc., PCI | HealthDev and Wildflower Health.
Pedro Juan Vergne-Morell, MBA
Co-Chairman and Board Member
Pedro Juan has more than 23 years of operations, product, services, marketing and C-suite management experience.
As Co-Chairman and Board member of PCI | HealthDev, Pedro Juan works closely with the board and the management team of the Company to further refine the Company's business model and to accelerate the growth of the Company.
Pedro Juan has honed his business acumen by working at technology startups (e.g., InfoSpace and JP Mobile, now Good Technology owned by BlackBerry Limited) to Fortune 100 companies such as GTE (now Verizon Communications) and most recently Nokia, Inc. Prior to joining
PCI | HealthDev, Pedro Juan was the Director of Marketing and Product Development for Sendo Mobile Phones for North and South America, Launch Manager for Latin America and Manager for North American Regional Carriers and Open Distribution at Nokia, Inc.
Most recently, Pedro Juan served as COO for PCI | HealthDev from April 2009 to July 2010 when he was promoted to President and CEO of the Company until December 2016. Over his career, Pedro Juan has focused on operations, product and service innovation and has been recognized with numerous intra company and industry awards relating to innovations in products and services. Pedro Juan has a proven track record of leading business growth by developing innovative and competitive services/solutions to build demand and brand awareness. He also helped to consistently drive sustainable short and long-term revenue growth via successful segmentation strategy and customer diversification implementations. In 2008 he was awarded a POPAI Award for Best of Industry Award.
In addition to holding a Board position at PCI | HealthDev as Co-Chairman, Pedro Juan also holds Board positions at Caduceus Medical Holdings, Inc. and PVM Consulting, LTD, d/b/a MonteSacro Capital Partners.
Pedro Juan holds a Bachelors Degree in International Relations and Economics from the University of Chicago and an MBA from the University of Texas at Dallas in Marketing and Finance. Most recently he completed an Advanced Management Programme with INSEAD. In addition to English, Pedro Juan is fluent in Spanish and French.
Pedro Vergne-Marini M.D.,
FACP, FACC, FASN
Founder and Board Member
Dr. Vergne-Marini has over 35 years of experience in patient care and healthcare-related businesses.
As founder of PCI | HealthDev, Dr. Vergne-Marini is responsible for establishing and implementing the Company's overall corporate business strategy. He brings over 35 years of experience in patient care and healthcare-related businesses.
Prior to founding the Company, Dr. Vergne-Marini was the President and CEO of Dallas Nephrology Associates and Chairman of the Board of Renaissance Health Care. While currently retired, he was the co-founder and Program Director for Transplantation and Chief of Nephrology at Methodist Dallas Medical Center. From 1981-2014, he was Clinical Professor of Medicine at the University of Texas Southwestern Medical School, and the Managing Partner for multiple physician real estate partnerships.
In addition to holding a board position at PCI | HealthDev, Dr. Vergne-Marini serves as Director at Caduceus Medical Holdings, Inc. and serves on the Board of PVM Consulting, LTD, d/b/a MonteSacro Capital Partners.
Dr. Vergne-Marini holds a Bachelor of Science degree in Chemistry from the University of Puerto Rico, and an M.D. degree from the University of Maryland Medical School. He completed Internship and Residency programs and the NIH Fellowship in Cardiology at the University Hospital of the Puerto Rico School of Medicine, where he was Chief Resident. Dr. Vergne-Marini then completed his NIH Nephrology Fellowship at the University of Texas Health Science Center, University of Texas Southwestern Medical School in Dallas. He is board certified with the Diplomat National Board of Medical Examiners, Diplomat American Board of Medicine, and Diplomat American Board of Nephrology. Dr. Vergne-Marini is a member of multiple medical societies of nephrology, including being a founding member of the American Society of Transplant Physicians and the Texas Transplant Society.
Mats has more than 30 years of global experience in healthcare companies.
Mats Wahlström has extensive experience in the healthcare industry, having served as CEO and CFO of large international companies in the renal field. Mats currently serves as Executive Chairman of KMG Capital Partners, LLC, board member of PCI | HealthDev and Director of Caduceus Medical Holdings, Inc. He also serves as a Lead Director and Chairman of the Audit/Finance Committee of Coherus Biosciences, a public biotech company. He currently serves on the Boards of Getinge AB and Alteco Medical AB, both public companies. He is the Chairman of the Boards of Triomed AB and Surefire Medical, Inc. and is also on the board of Circuit Clinical, Inc.
From January 2004 through December 2009, Mats served as Co-CEO of Fresenius Medical Care North America, and from November 2002 through December 2009 as President and CEO of Fresenius Medical Services, which operated more than 1,700 dialysis clinics in the U.S. Prior to joining Fresenius Medical Care, he held various positions at Gambro AB, including President and CEO of Gambro North America and Gambro Healthcare, Inc., as well as CFO of the Gambro Group.
Mats has a Bachelor of Science in Economics and Business Administration from the University of Lund, Sweden.
Javier Vergne-Morell, JD
Javier has more than 15 years of senior-level business and strategy development, IPO, M&A and legal experience.
Javier is responsible for helping with the development of long-term strategic growth plans as well as providing guidance to the Company's legal and business development teams.
Previously, Javier served as Vice President of Business Development for Renal Ventures Management, LLC where he oversaw all acquisitions, de novo development, and ongoing physician relationships. Mr. Vergne-Morell was also Director of Strategic Relationships for Broadlane, Inc, a healthcare-related organization specializing in supply chain cost management, labor and clinical staffing, equipment planning and information technology.
Javier has represented numerous emerging growth technology companies from early stage angel and venture capital financing through initial public offerings at Gunderson, Dettmer, Stough, Villeneuve, Franklin & Hachigan LLP, and has represented international corporations in cross border transactions and international securities issues at the global law firm Linklaters.
In addition to holding a board position at PCI | HealthDev, Javier also holds board positions at Caduceus Medical Holdings and PVM Consulting, LTD, d/b/a MonteSacro Capital Partners.
Javier holds a Bachelor of Arts degree from Tulane University and a J.D. from Georgetown University Law Center.
James Cotton, Jr., M.D.
Dr. Cotton has over 45 years of experience in patient care and healthcare research. In addition to his Board position with PCI | HealthDev, Dr. Cotton currently practices internal medicine and nephrology at Tyler Nephrology Associates. He previously held positions as Chief of Staff at East Texas Medical Center, on the executive Committee and Medical Review Board of the End Stage Renal Disease Network 14, as Chairman of the Medical Review Board, as a member of the Kidney Health Care Advisory Committee, and on the Medical Advisory Board of the Renal Care Group.
Dr. Cotton holds a Bachelor of Science degree in Chemistry from Baylor University. He earned his M.D. degree and completed the Internship and Residency programs at the University of Texas. He is board certified with the American Board of Internal Medicine and the American Board of Internal Medicine/Nephrology. He served as an Instructor for the Clinical Associate Program, and later as Director of Hemodialysis and Clinical Consultant of Nephrology as Lieutenant Commander at Navy Hospital, Portsmouth, Virginia. Dr. Cotton has memberships with the Renal Physicians Association, the Smith County Medical Society, and the Texas Medical Association.
PCI | HealthDev Executive Leadership
Jeff Kroll, MBA
Chief Executive Officer
Jeff has more than 15 years of experience in real estate development and finance.
As CEO, Jeff provides strategic direction and manages the day-to-day activities of PCI | HealthDev. He oversees real estate development, operations, finance, legal, compliance, and business development at
PCI | HealthDev. He works closely with company executives and staff to ensure projects run smoothly from inception through completion and performs a wide variety of activities related to acquisitions, finance, development, asset management, and dispositions of real estate.
Jeff joined PCI | HealthDev in 2012 as Senior Vice President, Business Development and Asset Financing, then moved on to become Chief Operating Officer. Prior to joining PCI | HealthDev, Jeff was Vice President of Real Estate for Frontier Renewal, an urban infill real estate company focused on redeveloping environmentally impaired properties for new commercial and residential uses.
Jeff is an active member of numerous commercial real estate and healthcare professional organizations.
Jeff holds a Bachelor of Arts degree in Broadcast Journalism from the University of Colorado, and an MBA specializing in Real Estate Investment and Finance from the University of Denver.
Greg Pakes, CPA
Chief Financial Officer
Greg has more than 30 years of accounting, auditing, M&A, tax and financial management experience.
As CFO, Greg leads the Company's accounting function, as well as various associated FP&A activities and financial modeling of prospective real estate development projects. This includes the design, implementation and execution of accounting policies and procedures, internal accounting control systems, internal and external reporting systems, budgeting and forecasting mechanisms and all other elements of an accounting environment.
Prior to PCI | HealthDev, Greg held leadership positions in Utilities & Infrastructure, Industries & Machines Manufacturers, Nonresidential Buildings, Data Centers & Networks and Residential with Schneider Electric Buildings, America, Inc., a subsidiary of Schneider Electric, which offers integrated solutions across multiple market segments.
He earned his Bachelor's degree in Accounting from Texas A&M University, is a CPA, and has considerable accounting and finance experience in manufacturing and construction companies, holding Controller roles in both central finance and business unit organizations.
Andrew T. Carnahan
SVP, Real Estate Development
Andrew has more than 20 years of real estate development experience.
As Senior Vice President of Real Estate Development, Andrew leads and manages PCI | HealthDev's project development team to best align with the development pipeline, as well as the funding and development process of each project.
Prior to joining PCI | HealthDev, Andrew was President of ForeSite Development, a commercial and residential urban planning and development company. In addition, Andrew brings 20 years of "top-to-bottom" real estate development experience ranging from real estate feasibility, sensitivity analysis and loan procurement to managing and developing turnkey commercial real estate solutions. Andrew has personally developed and executed over $300MM in real estate projects, and managed the development of projects as large as 100,000 SF.
Andrew holds a Bachelor of Arts in Finance and Real Estate Finance from Southern Methodist University in Dallas, Texas.
VP of Client Services
As VP of Client Services, Tom is responsible for managing
PCI | HealthDev's relationships with potential investors and our partnership with Fresenius Kidney Care.
Tom brings more than 25 years of dialysis patient care, facilities, operations management, and physician partnering to PCI | HealthDev. Prior to joining PCI | HealthDev, Tom was Operations Regional Vice President, Intermountain Region for Liberty Dialysis (a Fresenius Medical Care company).
Tom received a Bachelor of Arts degree in Biology from Olivet College.
Adam Feldman, JD
Adam has 17 years of contract and real estate legal experience.
As General Counsel, Adam is responsible for overseeing a broad range of business critical transactional matters such as contracts, real estate matters (e.g., acquisitions, dispositions, syndications, leasing, development and construction matters), vendor agreements, supervising customer/vendor intercompany legal relations, NDAs, overseeing corporate governance work, and managing the Company's external legal counsel. In addition, Adam guides the Company on legal matters and provides strategic advice to senior management while mitigating risk and ensuring compliance with the Company's ethics and values.
Previously, Adam was external real estate counsel to PCI | HealthDev at the Denver-based law firm Brownstein Hyatt Farber Schreck, LLP, as well as external counsel to the firm's other healthcare real estate clients. Prior to joining the Brownstein law firm, Adam was a founding partner at Patterson, Anderson & Feldman, P.A. in Jacksonville, Florida.
Adam holds a Bachelor of Arts degree, magna cum laude, from the University of Miami and a J.D. with honors from the University of Florida College of Law. Adam is a member of both the Colorado Bar and the Florida Bar.
What Our Clients Say
I began working with PCI | HealthDev when we decided to build a de novo DaVita dialysis unit north of Des Moines, Iowa. I investigated several preferred builders recommended by DaVita, but in the end, settled on PCI | HealthDev as it became clear that their goals aligned best with mine and those of the dialysis provider. They were always available as well as patient, and they spent a good deal of time educating me about commercial real estate investing, a field entirely new to me. Their flexibility on the terms of the agreements, as well as their desire to satisfy us in every way possible, have shown this company to be an excellent business partner. I have no doubt that I made the right choice, and I look forward to working with them on other projects in the future.
Mark M. Belz, M.D., F.A.C.P.
President, Iowa Kidney Physicians, P.C.
Adjunct Clinical Associate Professor
University of Iowa Hospitals and Clinics
Department of Internal Medicine
PCI | HealthDev Parent Company
Caduceus Medical Holdings, Inc.
Caduceus Medical Holdings, Inc. (CMH) was founded in 2010 as an investment and holding company focusing on healthcare services and products. CMH is the majority owner of Physicians' Capital Investments, LLC d/b/a PCI | HealthDev. CMH is owned by two healthcare investment partnerships: KMG Capital Partners, LLC and MonteSacro Capital Partners.
To build a long-term investment portfolio of healthcare-related companies with strong business models, service concepts, technologies, and capable management teams, and to create value for investors.
To find businesses with distinct winning formulas targeting the right modalities, and successfully execute growth strategies by continuously building core capabilities and effective management teams.
To make financial investments in healthcare companies and build a portfolio of core operating companies focusing on free cash flow generation and long-term value creation, with ownership in core operating companies of 25% or greater.
Target investment opportunities:
• Healthcare real estate development
• Healthcare services
• Web-based healthcare services
• Medical devices ("early growth capital")
Strength in Experience
The CMH management team leverages their broad healthcare experience from many years in senior executive positions and medical leadership with deep knowledge of:
– Kidney Transplantation
– Dialysis Products
– Dialysis Services
– Cardiovascular Products
– Clinical Laboratory
– Ambulatory Surgery Centers
– Physician Practice Management
– Pain Management
– Clinical Quality Improvement
– Disease Management
– Blood Component Technology
– Immunoabsorption Products
– Apheresis Services
– Anesthesia Products
– Ventilator Products
– Provider Value Ratings
(Hospitals, Physicians, LTC, etc.)
– Hospital/Physician Lead Generation
– Consumer Digital Media Properties
– Health Care Real Estate Solutions
Contact Caduceus Medical Holdings:
Seventeenth Street Plaza
1225 17th Street, Suite 1750
Denver, CO 80202